Thursday, October 23, 2025

Latest

Starbucks: Analysts Expect Q1 Revenues Of $7.95 Billion

Starbucks (NASDAQ: SBUX) will be reporting its first quarter financial results on February 1st before the market opens. Analysts have a consensus $121.97 12-month price target on the company, via a total of 37 analysts, with 9 analysts having strong buy ratings.

Nine analysts meanwhile have buy ratings, 18 analysts have a hold rating and a single analyst has a strong sell rating on the company. The street high comes from Kalinowski Equity Research with a $148 price target, and the lowest target sits at $96.

26 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 26 analysts is $7.95 billion; this number has been flat since October 30th. The highest revenue estimate is $8.18 billion, while the lowest is $7.4 billion.

Onto EBITDA estimates, there are currently 18 analysts who have first-quarter EBITDA estimates. The mean is currently $1.66 billion, with this number having been revised downwards from $1.71 billion at the end of October. The street high estimate currently sits at $1.82 billion in EBITDA and the lowest is $1.49 billion.

Analysts estimate that quarterly earnings per share will come in at $0.80, with this number flat since the end of October. The street high sits at $0.90 and the lowest estimate is $0.72 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Friday, September 17, 2021, 10:59:00 AM

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM

Well Health: PI Financial Raises Price Target To $7.00 On Back Of Circle Acquisition

This week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US...

Friday, September 4, 2020, 01:38:00 PM

BMO Expects Miners To Be Hit With Cost Inflation Headwinds In Q1 Results

On April 18, BMO released their first quarter preview on their metals and mining coverage,...

Thursday, April 21, 2022, 11:28:00 AM

BMO: Dollarama Is “Resilient During Periods Of High Inflation”

On September 9, Dollarama (TSX: DOL) announced its second quarter 2023 financial results. The company...

Thursday, September 15, 2022, 03:41:00 PM